Differential Impact of Intermittent vs. Sustained Hypoxia on HIF-1, VEGF and Proliferation of HepG2 Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24086875 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mélanie Minoves und 7 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1300, HP2 Laboratory, CHU Grenoble Alpes, University Grenoble Alpes, 38042 Grenoble, France. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Grenoble Alpes, INSERM, Fondation Agir pour les Maladies Chroniques.
Abstract (Originalsprache)
Obstructive sleep apnea (OSA) is an emerging risk factor for cancer occurrence and progression, mainly mediated by intermittent hypoxia (IH). Systemic IH, a main landmark of OSA, and local sustained hypoxia (SH), a classical feature at the core of tumors, may act separately or synergistically on tumor cells. Our aim was to compare the respective consequences of intermittent and sustained hypoxia on HIF-1, endothelin-1 and VEGF expression and on cell proliferation and migration in HepG2 liver tumor cells. Wound healing, spheroid expansion, proliferation and migration were evaluated in HepG2 cells following IH or SH exposure. The HIF-1α, endothelin-1 and VEGF protein levels and/or mRNA expression were assessed, as were the effects of HIF-1 (acriflavine), endothelin-1 (macitentan) and VEGF (pazopanib) inhibition. Both SH and IH stimulated wound healing, spheroid expansion and proliferation of HepG2 cells. HIF-1 and VEGF, but not endothelin-1, expression increased with IH exposure but not with SH exposure. Acriflavine prevented the effects of both IH and SH, and pazopanib blocked those of IH but not those of SH. Macitentan had no impact. Thus, IH and SH stimulate hepatic cancer cell proliferation via distinct signaling pathways that may act synergistically in OSA patients with cancer, leading to enhanced tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM U1300, HP2 Laboratory, CHU Grenoble Alpes, University Grenoble Alpes, 38042 Grenoble, France.
- CHU Grenoble Alpes, 38042 Grenoble, France.
- Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
ORCID-Profile: Mélanie Minoves, Florence Hazane-Puch, Giorgia Moriondo, Antoine Boutin-Paradis, Jean-Louis Pépin, Anne Briançon-Marjollet
Förderung
- University Grenoble Alpes
- INSERM
- Fondation Agir pour les Maladies Chroniques
Zitieren
APA
Minoves, M., Hazane-Puch, F., Moriondo, G., Boutin-Paradis, A., Lemarié, E., Pépin, J. L., Godin-Ribuot, D., & Briançon-Marjollet, A. (2023). Differential Impact of Intermittent vs. Sustained Hypoxia on HIF-1, VEGF and Proliferation of HepG2 Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24086875
Vancouver
Minoves M, Hazane-Puch F, Moriondo G, Boutin-Paradis A, Lemarié E, Pépin JL, et al. Differential Impact of Intermittent vs. Sustained Hypoxia on HIF-1, VEGF and Proliferation of HepG2 Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24086875
BibTeX
@article{Minoves2023,
author = {Minoves, Mélanie and Hazane-Puch, Florence and Moriondo, Giorgia and Boutin-Paradis, Antoine and Lemarié, Emeline and Pépin, Jean-Louis and Godin-Ribuot, Diane and Briançon-Marjollet, Anne},
title = {Differential Impact of Intermittent vs. Sustained Hypoxia on HIF-1, VEGF and Proliferation of HepG2 Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24086875}
}
EUVIMED